Overexpression of the proto-oncogene, MYC, was observed in dysplastic and cancer tissue, similar to a study of 47 CAC patients, where a higher rate of MYC amplification was reported compared to sporadic CRC, highlighting its importance to the CAC pathway, specifically (23). The gene discussed is MYC; the disease is cancer.